2007 Volume 9 Issue 4 Published: 28 August 2007
  

  • Select all
    |

    综述

  • 综述
    Cai Haodong;Sun Fengxia
    2007, 9(4): 229-234.
    Abstract ( ) PDF ( )
    Pyrrolizidine alkaloids (Pas) in the plants is one of the main causes of hepatic veno-occlusive disease occurring.Cases of hepatic veno-occlusive disease or liver damage associated with Pas-containing plants or medicinal herbs have been reported in America, England, China, and many other countries. There are more than six thousands kinds of the plants that contain Pas in the whole world. The Pas are primarily found in members of four plant families, I.e. (1) Compositae family: mainly in the genera Senecio, Ligularia, Eupatorium, Gynura, and Petasites; (2) Boraginaceae family: all plants of this family; (3) Leguminosae family: mainly in the genus Crotalaria; (4) Orchidaceae family: in the genus Liparis. There are thirty-eight kinds of Pas-containing medicinal herbs in China, and twelve of them are common in clinical practice as follows: Senecio scanden, Senecio campestri, Gynura segetum, Tussilago farfara, Herba Eupatorii, Herba lycopi, Radix Asters, Lithospermum, Heliotropium, Crotalaria sessiliflora, Crotalaria pallide, Liparis. The Pas have minimal toxicity in their original form, but their metabolites have hepatoxicity. In most instances of Pas liver toxicity in adults, the daily intake was several milligrams or hundreds of milligrams. However, it has been suggested by the WHO that the lowest intake of Pas that cause veno-occlusive disease in a human is just 0.015 mg/(kg·d). For a 70 kg adult, that would correspond to 1 mg total per day. The clinical manifestations of hepatic veno-occlusive disease are mainly refractory ascites, jaundice, hepatomegalia. There are no specific therapy for hepatic veno-occlusive disease, except symptomatic therapy and supportive therapy. Recently, the glucocorticosteroid or heparin therapy for Pas intoxication is reported, but their effect and safety are still under research. The authors consider that the education and monitoring for Pas-containing plants intoxication should be strengthened in our country.
  • 论著

  • 论著
    Zhou Ying①;Lu Min①;Tian Shuohan①;Liang Yan①;Zhang Huilin①; Cui Yimin*;Zhang Jun②;Zhang Liming②;Zhan Siyan③
    2007, 9(4): 235-238.
    Abstract ( ) PDF ( )
    Objective: To investigate the effects of gatifloxacin on blood glucose metabolism, and compared those with levofloxacin. Methods: In a retrospective cohort study, 300 hospitalized patients with infectious diseases while receiving gatifloxacin or levofloxacin in our hospital from September 2005 to August 2006 were assigned to two groups: gatifloxacin group (150 cases: diabetics 35 and nondiabetics 115) and levofloxacin group (150 cases: diabetics 38 and nondiabetics 112). The patients in the gatifloxacin group were administered with IV gatifloxacin 400 mg daily. The patients in the levofloxacin group were administered with IV levofloxacin 200~500 mg daily. The changes of blood glucose were analyzed in the two groups. Results: Dysglycemia in the gatifloxacin group was 6 cases (4.0%) and in the levofloxacin group was 1 case (0.7%). The differences between the two groups were statistically significant (P=0.044). In the galifloxacin group, of the diabetic patients, 2 (5.71%) were hyperglycemia, 1 (2.86%) was hypoglycemia, and 2 (5.71%) were both hypoglycemia and hyperglycemia; of the nondiabeticy patients, 1(0.87%) was hyperglycemia. In the levofloxacin group, of 38 diabetic patients, 1 (2.6%) was both hypoglycemia and hyperglycemia. Conclusion: The incidence of dysglycemia related to gatifloxacin is higher than that of levofloxacin. Blood glucose levels should be monitored carefully when gatifloxacin is used in patients, especially in diabetic patients.
  • 论著
    Chen Xue①;Qi Huanying①;Jiang Bin②;Zhang Jianzhong①
    2007, 9(4): 239-242.
    Abstract ( ) PDF ( )
    Objective: To investigate the relationship between bimolane/ethylimine treatment and secondary leukemia in patients with psoriasis. Methods: According to entry criteria, 189 patients hospitalized for psoriasis during the period from January 1990 to March 2006 were enrolled. Of the 189 patients, 39 patients with secondary leukemia entered into the case group (22 patients had received bimolane/ethylimine) and 150 patients without secondary leukemia entered into the control group (19 patients had received bimolane/ethylimine). The odds ratio(OR) of secondary leukemia, type of leukemia, and chromosome aberration rate in the patients who had received or had not received biomolane/ethylimine treatment were analyzed. Results: Of the 41 patients who had received bimolane/ethylimine treatment, 22 patients(53.66%) developed leukemia. And of the 148 patients who had not received bimolane/ethyline treatment, 17 patients(11.49%) developed leukemia (OR=8.92, 95% confidence interval=3.7621.44, P<0.01). Chromosome examination revealed that 10(83.33%) of 12 patients who had received bimolane/ethylimine treatment had chromosome aberration and 5(62.50%) of 8 patients who had not received bimolane/ethylimine treatment had chromosome aberration, the rate of chromosome aberration had no stastistically difference (P>0.05).Acute promyelocytic leukemia (M3) was the predominant type (53.85%) followed by acute granulocytic leakemia (M2) (25.64%). Conclusion: Secondary leukemia may be associated with bimolane/ethylimine used in the treatment for psoriasis. Granulooytic leukemia is the main form of leukemiainduced by bimolane/ethylimine.
  • 论著
    Diao Yiping
    2007, 9(4): 243-246.
    Abstract ( ) PDF ( )
    Objective:To compare the acute toxicity and irritation of water extracts and alcohol extracts from raw kansui and vinegared kansui.Methods:Raw kansui and vinegared kansui were extracted with water and alcohol,respectively.The extracts were prepared to solutions at different concentrations in water.Then acute toxicity test(LD50)in mice and eye and skin irritation test in rabbits was performed with the solutions.The control was normal saline.Results:The half lethal dose(LD50)and 95% confidence interval of alcohol extract of raw kansui were(24.64±6.57)mg/g and 18.07 to 31.21 mg/g,respectively.The half lethal dose(LD50)and 95% confidence interval of alcohol extract of vinegared kansui were(106.35±15.88)mg/g and 90.47 to 122.23 mg/g,respectively.The toxicity of alcohol extract of vinegared kansui was significantly diminished as compared with alcohol extract of raw kansui(P<0.01).The alcohol extract of raw kansui had severe irritation.The irritation of alcohol extract of vinegared kansui was markedly diminished.There was statistically significance in comparison between the two alcohol extract groups or between the both groups and the control group(all P<0.01).The water extract of raw kansui and vinegared kansui had no irritation.There was no statistically significance in comparison between the two groups and the control group.Conclusion:The water extract of raw kansui and vinegared kansui had no toxicity approximately.The toxicity and irritation of alcohol extract of vinegared kansui was markedly lower than that of raw kansui,it was comparatively safer.
  • 论著
    Wang Hong;Huang Ying;Zhang Shuwen;Ren Aimin;Zhang Lixia;Wang Bao'en
    2007, 9(4): 247-250.
    Abstract ( ) PDF ( )
    Objective:To analyze the etiology and clinical characteristics of pneumonia secondary to immunosuppressant regimens in renal transplant patients.Methods:The clinical data of 51 renal transplant patients with pneumonia receiving immunosuppressant regimens from four hospitals in Beijing between January 1999 and December 2004 were collected.The renal transplant patients were administered orally with cyclosporine 90~400 mg daily,mycophenolate mofetil 500~1 500 mg daily,and prednisone 5~30 mg daily for 3 months,and then the dosage was decreased to maintenance dose(Blood cyclosporine concentration was maintained in 100~200 ng/ml).The etiology,clinical manifestations,incidence of organs dysfunction and death to the renal transplant patients accompanied with pneumonia were analyzed.Results:The principal clinical characteristics of the 15 patients were interstitial pneumonia.The clinical manifestations were fever and cough.A chest X-ray revealed a blurred shadow.Of 51 cases,17 cases(33.33%)were bacterial infections,7 cases(13.73%)were virus infections,4 cases(7.84%)were pulmonary carinii infection,1 case(1.96%)was fungal infections,8 cases(15.69%)were unknown and 14 cases(27.45%)were mixed infections.Bacterial culture revealed Gram negative bacteria constituted the majority.Of total bacterial strain count,Gram negative bacteria accounted for 60% and Gram positive bacteria accounted for 40%.Adult respiratory distress syndrome and disseminated intravascular coagulation occurred in 11 cases(21.57%)and 4 cases(7.84%),respectively.Of all patients,11 cases(21.57%)died,and 40 cases(78.43%)were cured.Conclusion:Pneumonia is a severe complication in renal transplant patients receiving immunosuppressant regimens.Early diagnosis,anti-infective therapy,and adjustment of immunosuppressant regimens benefit to decrease the occurrence of pneumonia and to increase the cure rate.
  • 安全合理用药

  • 安全合理用药
    Geng Tongchao①;Shi Jianxiong②
    2007, 9(4): 251-255.
    Abstract ( ) PDF ( )
    Migraine is one of the most common disorders in neurological clinic.New advances in pathogenesis and drug therapy for migraine have been obtained in recent years.This paper presents the drug therapy for migraine including treatment of acute attacks and preventive therapy.The common drugs used to treat acute migraine attacks are nonsteroidal non-inflammatory drugs,triptans,ergot alkaloids,etc.And the drugs used for preventive therapy are tricycle antidepressants,anticonvulsants,β-blockers,calcium channel blockers,etc.This article reviews the therapeutic actions and potential adverse reactions of these drugs in order to benefit the safe and rational drug use in clinical practice.
  • 病例报告

  • 病例报告
    Chen Huiyun
    2007, 9(4): 255-261.
    Abstract ( ) PDF ( )
    A 21-year-old man with pneumonia was administered with IV azitromycin 0.5 g once daily.He developed persistence dull pain in the wrist and knee joint on day 2 after therapy.Physical examination showed every joint was normal.Laboratory tests revealed ASO and RF were also normal.Azithromycin was stopped and it was replaced with levofloxacin.Five days later,his arthralgia disappeared
  • 安全合理用药

  • 安全合理用药
    Zheng Ce;Mei Dan*
    2007, 9(4): 256-261.
    Abstract ( ) PDF ( )
    Warfarin is an oral anticoagulant used in the treatment and prophylaxis of thromboembolic disorders.Many factors affect warfarin's anticoagulant effect(enhancement or diminishment).These factors include genetics,diseases,drugs,herbal medicines,food,etc.Several polymorphisms of CYP2C9(mainly CYP2C9*2 and CYP2C9*3),liver function insufficiency,hyperthyroidism,heart failure,and interactions of warfarin with aspirin,clopidogrel,miconazole,angelica,fennel,celery,pineapple,onion,and garlic enhance the anticoagulant effect of warfarin.Gene mutation of VKORC1 and interactions of warfarin with rifampicin,carbamazepine,ginseng,green tea,and plenty vitamin K-containing preparations or diets diminish the anticoagulant effect of warfarin.Further more,some drugs such as phenytoin sodium can increase as well as decrease warfarin's anticoagulant effect.Understanding of these factors affecting the anticoagulant effect of warfarin,regular monitoring of INR,and individualizing medication are beneficial to safe and effective use of warfarin.
  • 滥用误用

  • 滥用误用
    Li Qinghong;Zhao Xiaohong;Qiao Shi;Li Fei
    2007, 9(4): 262-264.
    Abstract ( ) PDF ( )
    Objective:To study on the occurance of acute gastritis during detoxication of heroin-dependent patients.Methods:In retrospective study,the clinical data of 2 084 heroin-dependent patients with acute gastritis diagnosed by gastroscopy were collected,the relationship among gastritis and the administration,dosage,duration,and abstinence time of heroin abuse were analysed.Results:Of 2 084 patients,442 cases(21.21%)occurred acute gastritis.The incidence of acute gastritis was higher in patients using the higher doses,longer duration of medication,longer abstinence time,and intravenous injection(P<0.01).Conclusion:Heroin-dependent patients may occur acute gastritis during detoxication and care should be given to it.
  • 病例报告

  • 病例报告
    Mao Sufang;Yan Tingnian
    2007, 9(4): 264-266.
    Abstract ( ) PDF ( )
    A 55-year-old woman with headache caused by mild cerebral vasospasm received nimodipine 30 mg thrice daily.Ten days later,the patient developed distending pain of renal region,frequent nocturia,dark and turbid urine.The urine routine test revea-led protein(+++),blood cell(+++),glucose(+).Renal function examination showed the following values:BUN 6.1 mmol/L,Cr 129.3 μmol/L.Nimodipine was stopped.She was administered with carbazochrome 5 mg and vitamin K 4 mg thrice daily.Five days later,the symptoms disappeared.The reexaminations showed that urine routine and renal function were normalized.
  • 滥用误用

  • 滥用误用
    Li Mengying;Gan Qiongping;Li Zhuoman
    2007, 9(4): 265-266.
    Abstract ( ) PDF ( )
    A 21-year-old female with lumbar pain took phenylbutazone 0.2 g thrice daily and prednisone 10 mg thrice daily.About 26 days later,she developed a fever,dark urine,oedema,skin rash.Three days later,the drugs were stopped,but her symptoms continued aggravating.Nine days later,she was admitted.Her body temperature was 38.7 ℃ and pulse was 112 beats/min.She presented with severe yellowing of skin and sclera.Laboratory tests revealed the following values:Tbil 190.9 μmol/L,Dbil 132.2 μmol/L,Alb 29 g/L,Glob 31 g/L,ALT 251 U/L,AST 64 U/L,ALP 233 U/L,γ-GT 251 U/L,LDH 594 U/L,WBC 13.5×109/L.A lumbar MRI showed the 3rd and 4th lumbar vertebral body tuberculosis.The patient was given the anti-infective therapy,supportive therapy,methylprednisolone pulse therapy,and plasmapheresis.But her jaundice was aggravated gradually,and she developed abdominal distention,oliguresis,deep red-cloured tabular ecchymosis on trunk and limbs.Her levels of BUN and Cr were 15.5 mmol/L and 189 μmol/L,respectively.A B-scan ultrasound displayed a great quantity of seroperitoneum.A blood routine test revealed the values as follows:WBC 1.7×109/L,RBC 2.04×1012/L,Hb 58 g/L,PLT 19×109/L.A bone marrow examination showed acute aplastic crisis.The patient died on day 9 after admission
  • 中毒救治

  • 中毒救治
    Huang Jing①;Liu Fang①②;Zhai Suodi①②*
    2007, 9(4): 267-271.
    Abstract ( ) PDF ( )
    Sodium nitroprusside is a rapid and short-acting vasodilator.It is used in the treatment of hypertensive crises and severe heart failure.Sodium nitroprusside is rapidly metabolized into cyanide,which is further metabolized to thiocyanate.Therefore,cyanide poisoning or thiocyanate intoxication from their accumulation may occur with high-doses,prolonged administration of sodium nitroprusside.Should the patients develop metabolic acidosis,central nervous system depression,and cardiovascular instability that may consider cyanide poisoning or thiocyanate intoxication,and sodium nitroprusside should be stopped immediately.The patients should be given systematic therapy and antidote.The common antidotes are sodium nitrite,methylthioninium chloride,sodium thiosulfate,and hydroxocobalamin.The thiocyanate concentrations should be monitored if treatment continues for over than 3 days,and cyanide concentrations should also be monitored.Cyanide toxicity from sodium nitroprusside may be prevented by concomitant administration of sodium thiosulfate.The patient with renal impairment may use fenoldopam to replace sodium nitroprusside.
  • 病例报告

  • 病例报告
    Bi Jinlian
    2007, 9(4): 271-271.
    Abstract ( ) PDF ( )
    A 40-year-old man with fracture of left thumb was given intravenously ossotide injection 50 mg once daily.On day 6 during the infusion,the patient suddenly developed severe thoracalgia,abdominalgia,and lumbago,a fever(T 39 ℃),generalised cyanosis,and dyspnea.Two hours later,his blood pressure was decreased from 140/110 mmHg on admission to 70/50 mmHg,accompanied by unconsciousness and gatism.After discontinuation of ossotide injection instantly,he received antishock therapy.One hour later,he recovered.His blood pressure was 100/70 mmHg and respiration rate was 20 breaths/min.
  • 中毒救治

  • 中毒救治
    Wu Qiong;Guo Xiaoqing;Pu Xiuhong;An Tao
    2007, 9(4): 272-272.
    Abstract ( ) PDF ( )
    A 3-year-old boy took atenolol 62.5 mg by misuse.Three hours later,he developed restlessness,pale,coldness of extremitis,mild cyanosis,sweating on forehead.His blood pressure was too low to measure.His HR was 80 beats/min.After the treatments of emetic,gastric lavage,catharsis,and fluid replacement,his symptoms were relieved.His blood pressure returned to 100/70 mmHg,and HR increased to 100 beats/min.He was cured and discharged
  • 药源性疾病

  • 药源性疾病
    Xu Saihui;Lei Zhaobao
    2007, 9(4): 273-276.
    Abstract ( ) PDF ( )
    Syncope refers to a temporary loss of consciousness due to brief generalized insufficient blood supply to the brain.The causes of syncope are myriad such as cardiovascular diseases,low blood glucose,drugs,and so on.Drug-induced syncope accounts for 2%~9%.Drug-induced sycope is classified into four types,I.e.cardiac syncope,orhostatic hypotensive syncope,vasodepressor syncope,and other syncope.Its clinical presentations are dizziness,palpitation,nausea,sweat,myasthenia of limbs,unconsciousness,fall,etc.The most common drugs are cardiovascular drugs,antipyretic analgesics,and antibacterials.The treatment for drug-induced syncope usually is cessation of the drug and to let the patient lie flat.But the method of treatment for cardiac syncope induced by drug varies with the patient's condition.The main preventive measures for drug-induced syncope include the choice of appropriate drug and dosage,control of concentration and speed to intravenous medication,caution in drug combinations,and enhancement of monitoring.
  • 病例报告

  • 病例报告
    Lei Li;Luo Jizheng;Meng Junying;Song Yingxin;Bai Yun;Wang Lun;Wang Quan;Wu Liqun
    2007, 9(4): 277-278.
    Abstract ( ) PDF ( )
    Two old men with lung cancers died from interstitial 1ung disease during treatment with erlotinib.The first patient,an 84-year-old man with adenocarcinoma of lung and osseous metastasis was given erlotinib 150 mg once daily for osteodynia.At the first night,he developed a fever(T 38.3℃),cough,and expectoration in spite of osteodynia relieved.After anti-infective therapy with ceftriaxone sodium,his body temperature returned to normal.But the patient's condition deteriorated gradually.After 11 days of erlotinib therapy,he developed dyspnea.His partial pressure of oxygen in arterial blood was 67.5 mmHg after treatment with oxygen 5 L/min.A chest X-ray revealed diffused interstitial change in the lungs.Erlotinib was withdrawn.The patient died of respiratory failure in the next day.The second patient,a 69-year-old man with right lung squamous carcinoma received chemotherapy,radiotherapy,and symptomatic therapy.A CT scan revealed the focus slightly decreased in size,and the patient's condition was stable.After 2 days of receiving erlotinib 150 mg once daily,he developed skin rash on face and trunk.His rash recovered by local symptomatic treatment.After 29 days of administration of erlotinib,he developed a fever,aggravation of cough and short breath.His count of WBC was 10.2×109/L.The efficacy of anti-infective therapy was not apparent.Repeat CT scan showed diffused interstitial change in the 1ungs on day 35.Erlotinib was discontinued.The next day,the patient's condition aggravated suddenly.He presented with severe dyspnea.Arterial blood gas analysis revealed hypoxemia.On day 3 he died of respiratory failure.
  • 病例报告
    Cao Yantao;Li Zhenzhou;Zhang Xin;Zhang Yaofen
    2007, 9(4): 279-280.
    Abstract ( ) PDF ( )
    A 78-year-old man with facial paralysis was given nifedipine,vitamin B1,cobamamide,sodium asscinate,and Xue-saitong injection after admission.And zolpidem at bedtime was given for his inability to sleep.During the 3 days of zolpidem treatment,in the first day,the patient fell asleep within 1 hour after ingestion of zolpidem 10 mg.And 3 hours later,the man got up,walked and talked with somebody while asleep.But he had no memory of that event subsequently.In the second day,the patient took zolpidem 5 mg,and no such behaviours occurred.In the third day,he developed the behaviours again 5 hours after ingestion of zolpidem 10 mg.After discontinuation of zolpidem,the behaviours did not recur.
  • 病例报告
    Jin Zhenbo
    2007, 9(4): 280-281.
    Abstract ( ) PDF ( )
    A 34-year-old woman with hyperthyroidism was given propylthiouracil 100 mg thrice daily and diazepam 10 mg thrice daily.Nineteen days later,she developed a fever(T 38.3 ℃),skin rash,pharyngodynia,nausea,and so on.Laboratory test revealed:WBC count 1.18×109/L,neutrophile granulocyte count 0.50×109/L,ALT level 457 U/L,AST level 120 U/L,blood glucose level 8.49 mmol/L.Propylthiouracil was withdrawn.The patient was treated with reduced glutathione,silybin meglumine,loratadine,diazepam,and filgrastim.After 4 weeks of therapy,the patient's blood routine returned to normal limits and her liver function obviously improved.
  • 病例报告
    Xu Lanying
    2007, 9(4): 281-282.
    Abstract ( ) PDF ( )
    A 65-year-old man started receiving antituberculous treatment with isoniazide 0.3 g/d,rifampin 0.45 g/d,pyramide 0.5 g twice daily,and ethambutol 0.75 g/d after the operation of lymphoid tuberculosis.After 18 days of treatment,he developed chilly,hypodynamia,cough,and chest distress.He was treated with paracetamol and amoxicillin.The next day,his cough was aggravated and followed a fever(T 38 ℃),dyspnea,inability to lie flat,cyanosis of the lips,wheezing in the lungs.After symptomatic therapy,he relieved.After discontinuation of the antituberculous drugs,the asthma-like symptom disappeared.One week later,isoniazide was given to the patient at first,then,rifampin and pyramide were added respectively to his regimen every three days.The asthma-like symptom did not appear.But within several hours after addition of ethambutol,the asthma-like symptom reappeared.
  • 病例报告
    Liu Ying;Chen Ranhong
    2007, 9(4): 282-283.
    Abstract ( ) PDF ( )
    Two old women developed abdominal colic,diarrhea,and arrhythmia after treatment with salmon calcitonin injection.The first patient,a 67-year-old woman was hospitalized with lumbar intervertebral disk degenerative disease and osteoporosis.She was given oral calcium gluconate 1 g twice daily and IM salmon calcitonin 50 IU once daily after an intradermal skin test was negative.Thirty minutes after injection,she developed abdominal colic and excreted yellow mushy stool.Two hours later,she developed palpitation.An ECG showed arrhythmia,paroxysmal ventricular tachycardia and abiogeny atrial premature beats.The symptoms lasted for 1 hour and then disappeared.After 3 days of administration,her symptoms were aggravated and she developed bilateral palpebral oedema.Then the regimen was changed to salmon calcitonin 50 IU once weekly.Two weeks later,these symptoms still existed.Salmon calcitonin was discontinued.Five days later,the symptoms relieved.An ECG showed normal.The second patient,a 65-year-old woman with lumbar intervertebral disk herniation and degeneration of bilateral knee joints was admitted.Laboratory test revealed her blood calcium level was 2.02 mmol/L.She was administered with IM salmon calcitonin 50 IU after a negative intradermal skin test.Two hours later,she developed abdominal colic,urinary frequency of micturition,urgency of urination,and diarrhea.An ECG showed sinus tachycardia.Six hours later,her symptoms relieved spontaneously.She did not receive the second injection.
  • 病例报告
    Liu Jinxian;Liang Xiuyan
    2007, 9(4): 284-285.
    Abstract ( ) PDF ( )
    An 82-year-old man,suffering coronary heart disease and hypertension for many years,was hospitalized for treatment.He started receiving amlodipine 5 mg once daily.A week later,he developed lower limbs oedema.Fifteen days later,he developed anasarca further.Examination revealed him pleural and pericardial effusion.In consideration of cardia insufficiency,his amlodipine dosage was increased to 5 mg twice daily.The next day,his anasarca aggravated rapidly.Amlodipine was discontinued.Then he was administered nifedipine controlled-release tablets 30 mg once daily and frusemide 20 mg twice daily.Two days later,his oedema relieved gradually.After one month,the patient's oedema resolved completely and he was discharged.Five months later,the patient was admitted again for hypertension(180~170/120~100 mmHg).The dose of nifedipine controlled-release tablets was increaded to 30 mg twice daily.Twenty days later,he developed oedema of eyelid and lower limb again.An ultrasonic cardiography showed mil…更多d pericardial effusion.Nifedipine controlled-release tablets was decreased to 30 mg once daily,and frusemide 20 mg twice daily was added to his regimen.Three days later,the oedema resolved gradually.The patient recovered and was discharged after 3 weeks
  • 病例报告
    Wang Laicheng;Lti Dongmei
    2007, 9(4): 285-286.
    Abstract ( ) PDF ( )
    A 33-year-old man and an 18-year-old man started receiving chemotherapy with VDCLP regimens(vincristine,daunomycin,cyclophosphamide,asparaginase,and dexamethasone)for acute lymphoblastic leukemia.On day 19 of chemotherapy,they continued receiving intravenously asparaginase 10 000 U and dexamethasone 10 mg once daily,and other drugs were discontinued.After 5 days of using the two drugs,they developed thirst,dry mouth,polydipsia,polyuria,and so on.Laboratory tests showed:fasting blood glucoses >30 mmol/L and urine glucose(++++).After withdrawal of the two drugs and insulin therapy,their fasting blood glucoses returned to normal.
  • 病例报告
    Chu Yanqi
    2007, 9(4): 287-287.
    Abstract ( ) PDF ( )
    A 52-year-old man with colonic cancer was administered with IV oxaliplatin(Eloxatin)150 mg after operation.In the cycle 5,the patient received IV oxaliplatin(Aiheng)and developed cough and skin flush.In the cycle 6,he presented with skin flush,pruritus,cough,dyspnoea,and hypotension(63/45 mmHg)after 10 minutes of intravenous infusion of oxaliplatin(Eloxatin).Anaphylactic shock was diagnosed.The symptoms relieved after symptomatic therapy.
  • 病例报告
    Zhou Xianghong;Zhu Xiaohua;Li Ling;Wu Hong
    2007, 9(4): 288-288.
    Abstract ( ) PDF ( )
    A 55-year-old woman with type 2 diabetes mellitus took glimepiride 2 mg once daily at half hour before breakfast.Three days later,she developed vertigo.A TCD examination revealed cerebral arteriosclerosis and vertebra-basilar artery insuf-ficiency.She was received anti-vertigo therapy with flunarizine,difenido,and scopolaline.But the efficacy of the therapy was not apparent.After 3 days of therapy,the dose of glimepiride was increased to 4 mg once daily for increased blood glucose.After one hour of administration,her vertigo was aggravated,and accompanied with nausea and vomit.Because the patient could not take glimepiride,the vertigo was relieved at night of the next day and disappeared 4 days later.One hour of using glimepiride again later,the vertigo was recurred.Glimepiride was stopped.28 hours later,the patient's symptoms of vertigo disappeared
  • 病例报告
    Pang shufang①;Miao Zhenli②
    2007, 9(4): 289-289.
    Abstract ( ) PDF ( )
    A 53-year-old woman with colpitis mycotica received an intravaginal application of nysfungin powder 1×106 U after the treatment with infrared instrument.Eleven hours later,she developed a high fever(T 39.2 ℃)and palpitation.An ECG showed sinus tachycardia.After symptomatic treatment,she recovered.The next day,the similar symptoms reappeared after she received nysfungin again,and she was cured after antianaphylaxis therapy.The nysfungin powder was replaced with miconazole suppositories 400 mg and then it was inserted into the vagina after treatment with infrared instrument.No such adverse reactions occurred.
  • 病例报告
    Chen Yuhuang①;Tang Yonglin②;Wang Xizhen②
    2007, 9(4): 290-290.
    Abstract ( ) PDF ( )
    A 17-year-old man was given hydroxyethyl starch 130/0.4 sodium chloride injection 500 ml by intravenous infusion at a rate of 300 ml an hour after the operation for abdominal incised wound.About 20 minutes after the initiation of infusion,the patient developed restlessness,urticaria on the nape of his neck and his chest.After antianaphylaxis therapy,his urticaria disappeared.
  • 中药不良反应

  • 中药不良反应
    Ma Huizhen;Guo Meizi;Zhang Wei
    2007, 9(4): 291-292.
    Abstract ( ) PDF ( )
    A 77-year-old man with primary hypertension was administered with losartan potassium 50 mg once daily for a prolonged treatment.Xuezhikang tablets 0.6 g twice daily were added to his regimen for increased blood lipids.After 56 days of administration of Xuezhikang tablets,the patient developed dark urine,yellowing of skin,and mild hypodynamia.Laboratory tests revealed the following values:ALT 1 017 U/L,AST 511 U/L,AKP 312 U/L,γ-GT 236 U/L,Tbil 91.2 μmol/L,Dbil 63 μmol/L,Alb 39.2 g/L,cholinesterase 6.6 U/L,LDH 244 U/L,BUN 7.4 mmol/L,Cr 101 μmol/L,urobilinogen(+),urobilirubin(+++).After withdrawal of Xuezhikang tablets and liver protective treatment with silybin meglumine,reduced glutathione,and alprostadil injection for about one month,his liver function returned to normal.
  • 中药不良反应
    Yang Yepeng;Wang Xiaohui
    2007, 9(4): 292-293.
    Abstract ( ) PDF ( )
    Two psychotic patients developed leucopenia during treatment with Qingkailing injection for upper respiratory tract infection.The first patient,a 30-year-old woman with paranoid personality disorder received long-term treatment with venlafaxine 150 mg daily and quetiapine fumarate 0.2 mg daily.On day 3 after admission,she occurred upper respiratory tract infection.Laboratory test revealed a WBC count of 5.7×109/L.She started receiving Qingkailing injection 40 ml + sodium chloride injection 0.9% 500 ml once daily by intravenous infusion.The next day,her WBC was decreased to 3.2×109/L.After 5 days of administration with Qingkailing injection,her WBC was decreased to 2.0×109/L.On day 6 after the cessation of Qingkailing injection,her WBC was increased to 4.7× 109/L.On reexaminations,the WBC counts were in normal limits.The second patient,a 35-year-old woman with bipolar affective disorder developed upper respiratory tract infection after 2 months of admission.She was administered intraven ously with Qingkailing injection 30 ml + glucose injection 5% 500 ml once daily and WeiC Yinqiao 2 tablets thrice daily.On day 5,her symptom of upper respiratory tract infection disappeared and her body temperature returned to normal.But her WBC was decreased from 7.8×109/L to 3.1×109/L.Qingkailing injection was discontinued.One week later,her WBC was increased to 5.8×109/L.During 3 months of follow-up,the WBC was normal.
  • 中药不良反应
    Wang Ying
    2007, 9(4): 293-294.
    Abstract ( ) PDF ( )
    Two women with coronary heart disease and angina pectoris were administered intravenously with Ciwujia injection 60 ml.After 2 to 3 minutes of therapy,they suddenly developed dyspnoea,cyanose of the lips,polypnea,rhonchi in the lungs.Ciwujia injection was stopped immediately.After administration of oxygen,IV glucocorticoid,and other symptomatic therapy,the patient recovered gradually.
  • 中药不良反应
    Wang Qi
    2007, 9(4): 294-301.
    Abstract ( ) PDF ( )
    A 32-year-old man with waist sprains pasted a Jieguling patch.Four hours later,he developed facial oedema,sporadic rash and vesicle on the skin of waist,back,limbs,and neck,and accompanied a mild fever(T 38 ℃).Two days later,he was hospitalized.A laboratory test showed his renal function was normal.Then he was given dexamethasone 5 mg intravenously once daily.After one day of therapy,his symptoms were obviously relieved.Eleven days later,he almost restored.
  • 药物评介

  • 药物评介
    Ding Qingming①;Ren Liankun②
    2007, 9(4): 295-301.
    Abstract ( ) PDF ( )
    Levetiracetam,an analogue piracetam,is one of newer antiepileptic drugs used as adjunctive therapy(added to other antiepileptic drugs)of partial seizures,myoclonic seizures,and primary generalized tonic-clonic seizures.Levetiracetam is rapidly and almost completely absorbed after oral administration,and peak plasma concentration are usually achieved within 1.3 hours.The extent of bioavailability of levetiracetam is not affected by food.Levetiracetam is less than 10% bound to plasma proteins.Plasma half-life of levetiracetam is approximately 6~8 hours.The initial adult dose is 1 g in two divided doses on the first day of treatment,thereafter,the daily dose may be adjusted in increments of 1 g every 2 to 4 weeks until effective antiepileptic control is achieved,up to a maximum dose of 3 g daily.The most common adverse reactions to levetiracetam are somnolence,weakness,and dizziness.Levetiracetam should be used with caution and in reduced doses in patients with renal impairment and in patients with severe hepatic impairment.Withdrawal of levetiracetam therapy should be made gradually(reducing the daily dose by 1 g every 2 to 4 weeks),sudden withdrawal may induce an increase in the frequency of seizures.